A detailed history of Cubist Systematic Strategies, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 163,196 shares of WVE stock, worth $2.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
163,196
Holding current value
$2.19 Million
% of portfolio
0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.12 - $9.01 $835,563 - $1.47 Million
163,196 New
163,196 $1.34 Million
Q1 2024

May 15, 2024

BUY
$3.54 - $6.84 $241,739 - $467,089
68,288 Added 27315.2%
68,538 $422,000
Q4 2023

Feb 14, 2024

BUY
$4.16 - $6.87 $1,040 - $1,717
250 New
250 $1,000
Q1 2023

May 15, 2023

SELL
$3.58 - $6.3 $109,777 - $193,183
-30,664 Reduced 30.02%
71,489 $309,000
Q4 2022

Feb 14, 2023

BUY
$3.18 - $7.0 $305,066 - $671,531
95,933 Added 1542.33%
102,153 $715,000
Q3 2022

Nov 14, 2022

SELL
$2.37 - $4.28 $33,763 - $60,972
-14,246 Reduced 69.61%
6,220 $22,000
Q2 2022

Aug 15, 2022

BUY
$1.23 - $3.25 $25,173 - $66,514
20,466 New
20,466 $67,000
Q1 2022

May 16, 2022

SELL
$2.0 - $3.28 $22,528 - $36,945
-11,264 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$3.14 - $5.15 $17,703 - $29,035
-5,638 Reduced 33.36%
11,264 $35,000
Q3 2021

Nov 15, 2021

BUY
$4.89 - $7.12 $16,391 - $23,866
3,352 Added 24.74%
16,902 $83,000
Q2 2021

Aug 16, 2021

SELL
$5.65 - $7.47 $349,548 - $462,146
-61,867 Reduced 82.03%
13,550 $90,000
Q1 2021

May 17, 2021

BUY
$5.61 - $12.01 $285,605 - $611,429
50,910 Added 207.74%
75,417 $423,000
Q4 2020

Feb 16, 2021

SELL
$6.99 - $9.26 $68,341 - $90,535
-9,777 Reduced 28.52%
24,507 $193,000
Q3 2020

Nov 16, 2020

BUY
$8.49 - $19.54 $141,256 - $325,106
16,638 Added 94.29%
34,284 $291,000
Q2 2020

Aug 14, 2020

BUY
$7.44 - $11.29 $131,286 - $199,223
17,646 New
17,646 $184,000
Q1 2020

May 15, 2020

SELL
$6.94 - $14.22 $51,508 - $105,540
-7,422 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$7.99 - $37.6 $40,125 - $188,827
5,022 Added 209.25%
7,422 $59,000
Q3 2019

Nov 14, 2019

BUY
$19.17 - $27.4 $11,502 - $16,440
600 Added 33.33%
2,400 $49,000
Q2 2019

Aug 14, 2019

SELL
$22.93 - $42.84 $446,607 - $834,394
-19,477 Reduced 91.54%
1,800 $47,000
Q1 2019

May 15, 2019

BUY
$32.69 - $47.91 $691,556 - $1.01 Million
21,155 Added 17340.16%
21,277 $827,000
Q4 2018

Feb 14, 2019

SELL
$37.1 - $50.11 $27,787 - $37,532
-749 Reduced 85.99%
122 $5,000
Q3 2018

Nov 14, 2018

BUY
$36.35 - $55.2 $31,660 - $48,079
871 New
871 $44,000
Q1 2018

May 15, 2018

SELL
$32.45 - $54.7 $6,490 - $10,940
-200 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$21.8 - $39.35 $4,360 - $7,870
200
200 $7,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.16B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.